Literature DB >> 32918533

Systemic viral infection in children receiving chemotherapy for acute leukemia.

Constanze Buus-Gehrig1, Konrad Bochennek1, Marc T Hennies2, Thomas Klingebiel1, Andreas H Groll3, Thomas Lehrnbecher1.   

Abstract

Systemic viral diseases frequently occur in allogeneic hematopoietic stem cell transplantation, but data in children receiving chemotherapy for acute leukemia are scarce. We therefore collected and analyzed the published data on symptomatic infection from cytomegalovirus, herpes simplex virus, varicella zoster virus, parvovirus B19, or adenovirus in pediatric acute leukemia. Reports on 68 children were identified, of whom 16 patients have died from the infection. Further studies have to (1) evaluate the true incidence of these infections in pediatric acute leukemia, (2) their impact on outcome, and (3) whether a subpopulation of patients could benefit from screening and prophylactic strategies.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  acute leukemia; adenovirus; child; cytomegalovirus; herpes simplex virus; parvovirus B19; systemic viral disease; varicella zoster virus

Year:  2020        PMID: 32918533     DOI: 10.1002/pbc.28673

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  3 in total

Review 1.  Human Adenovirus Associated Hepatic Injury.

Authors:  Nan Zheng; Yan Wang; Hechen Rong; Kun Wang; Xiaoping Huang
Journal:  Front Public Health       Date:  2022-04-28

Review 2.  Neutropenia and Infection Prophylaxis in Childhood Cancer.

Authors:  Stephanie Villeneuve; Catherine Aftandilian
Journal:  Curr Oncol Rep       Date:  2022-03-01       Impact factor: 5.945

3.  Population Pharmacokinetics of Intravenous Acyclovir in Oncologic Pediatric Patients.

Authors:  Natalia Maximova; Daniela Nisticò; Giacomo Luci; Roberto Simeone; Elisa Piscianz; Ludovica Segat; Egidio Barbi; Antonello Di Paolo
Journal:  Front Pharmacol       Date:  2022-04-14       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.